Table of Content

1. Executive Summary
   1.1. Global Animal Drug Compounding Market Snapshot, 2025 and 2032
   1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Regulatory Landscape
   3.2. Product Adoption Analysis
   3.3. Value Chain Analysis
   3.4. Key Deals and Mergers
   3.5. PESTLE Analysis
   3.6. Porter’s Five Force Analysis
4. Global Animal Drug Compounding Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Mn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2023
       4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
   4.3. Global Animal Drug Compounding Market Outlook: Product
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019 - 2023
       4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
           4.3.3.1. CNS Agents
           4.3.3.2. Anti-Infective Agents
           4.3.3.3. Hormones and Substitutes
           4.3.3.4. Anti-inflammatory Agents
           4.3.3.5. Others
       4.3.4. Market Attractiveness Analysis: Product
   4.4. Global Animal Drug Compounding Market Outlook: Animal
       4.4.1. Introduction / Key Findings
       4.4.2. Historical Market Size (US$ Mn) Analysis, By Animal, 2019 - 2023
       4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Animal, 2025 - 2032
           4.4.3.1. Companion
               4.4.3.1.1. Cats
               4.4.3.1.2. Dogs
               4.4.3.1.3. Others
           4.4.3.2. Livestock
       4.4.4. Market Attractiveness Analysis: Animal
   4.5. Global Animal Drug Compounding Market Outlook: Formulation
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Mn) Analysis, By Formulation, 2019 - 2023
       4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Formulation, 2025 - 2032
           4.5.3.1. Oral
           4.5.3.2. Injectable
           4.5.3.3. Others
       4.5.4. Market Attractiveness Analysis: Formulation
5. Global Animal Drug Compounding Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2023
   5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Animal Drug Compounding Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
       6.2.1. By Country
       6.2.2. By Product
       6.2.3. By Animal
       6.2.4. By Formulation
   6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       6.3.1. U.S.
       6.3.2. Canada
   6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       6.4.1. CNS Agents
       6.4.2. Anti-Infective Agents
       6.4.3. Hormones and Substitutes
       6.4.4. Anti-inflammatory Agents
       6.4.5. Others
   6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal, 2025 - 2032
       6.5.1. Companion
           6.5.1.1. Cats
           6.5.1.2. Dogs
           6.5.1.3. Others
       6.5.2. Livestock
   6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Formulation, 2025 - 2032
       6.6.1. Oral
       6.6.2. Injectable
       6.6.3. Others
   6.7. Market Attractiveness Analysis
7. Europe Animal Drug Compounding Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
       7.2.1. By Country
       7.2.2. By Product
       7.2.3. By Animal
       7.2.4. By Formulation
   7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       7.3.1. Germany
       7.3.2. France
       7.3.3. U.K.
       7.3.4. Italy
       7.3.5. Spain
       7.3.6. Russia
       7.3.7. Türkiye
       7.3.8. Rest of Europe
   7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       7.4.1. CNS Agents
       7.4.2. Anti-Infective Agents
       7.4.3. Hormones and Substitutes
       7.4.4. Anti-inflammatory Agents
       7.4.5. Others
   7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal, 2025 - 2032
       7.5.1. Companion
           7.5.1.1. Cats
           7.5.1.2. Dogs
           7.5.1.3. Others
       7.5.2. Livestock
   7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Formulation, 2025 - 2032
       7.6.1. Oral
       7.6.2. Injectable
       7.6.3. Others
   7.7. Market Attractiveness Analysis
8. East Asia Animal Drug Compounding Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
       8.2.1. By Country
       8.2.2. By Product
       8.2.3. By Animal
       8.2.4. By Formulation
   8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       8.4.1. CNS Agents
       8.4.2. Anti-Infective Agents
       8.4.3. Hormones and Substitutes
       8.4.4. Anti-inflammatory Agents
       8.4.5. Others
   8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal, 2025 - 2032
       8.5.1. Companion
           8.5.1.1. Cats
           8.5.1.2. Dogs
           8.5.1.3. Others
       8.5.2. Livestock
   8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Formulation, 2025 - 2032
       8.6.1. Oral
       8.6.2. Injectable
       8.6.3. Others
   8.7. Market Attractiveness Analysis
9. South Asia & Oceania Animal Drug Compounding Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
       9.2.1. By Country
       9.2.2. By Product
       9.2.3. By Animal
       9.2.4. By Formulation
   9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       9.4.1. CNS Agents
       9.4.2. Anti-Infective Agents
       9.4.3. Hormones and Substitutes
       9.4.4. Anti-inflammatory Agents
       9.4.5. Others
   9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal, 2025 - 2032
       9.5.1. Companion
           9.5.1.1. Cats
           9.5.1.2. Dogs
           9.5.1.3. Others
       9.5.2. Livestock
   9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Formulation, 2025 - 2032
       9.6.1. Oral
       9.6.2. Injectable
       9.6.3. Others
   9.7. Market Attractiveness Analysis
10. Latin America Animal Drug Compounding Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
       10.2.1. By Country
       10.2.2. By Product
       10.2.3. By Animal
       10.2.4. By Formulation
   10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       10.4.1. CNS Agents
       10.4.2. Anti-Infective Agents
       10.4.3. Hormones and Substitutes
       10.4.4. Anti-inflammatory Agents
       10.4.5. Others
   10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal, 2025 - 2032
       10.5.1. Companion
           10.5.1.1. Cats
           10.5.1.2. Dogs
           10.5.1.3. Others
       10.5.2. Livestock
   10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Formulation, 2025 - 2032
       10.6.1. Oral
       10.6.2. Injectable
       10.6.3. Others
   10.7. Market Attractiveness Analysis
11. Middle East & Africa Animal Drug Compounding Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2023
       11.2.1. By Country
       11.2.2. By Product
       11.2.3. By Animal
       11.2.4. By Formulation
   11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       11.3.1. GCC Countries
       11.3.2. Egypt
       11.3.3. South Africa
       11.3.4. Northern Africa
       11.3.5. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       11.4.1. CNS Agents
       11.4.2. Anti-Infective Agents
       11.4.3. Hormones and Substitutes
       11.4.4. Anti-inflammatory Agents
       11.4.5. Others
   11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Animal, 2025 - 2032
       11.5.1. Companion
           11.5.1.1. Cats
           11.5.1.2. Dogs
           11.5.1.3. Others
       11.5.2. Livestock
   11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Formulation, 2025 - 2032
       11.6.1. Oral
       11.6.2. Injectable
       11.6.3. Others
   11.7. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Hoye's Pharmacy
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Vertisis Custom Pharmacy
       12.3.3. Smith Caldwell Drug Store
       12.3.4. Sixth Avenue Medical Pharmacy
       12.3.5. Dougherty's Pharmacy
       12.3.6. Triangle Compounding Pharmacy Inc.
       12.3.7. Medisca Inc.
       12.3.8. Wedgewood Pharmacy
       12.3.9. Millers Pharmacy
       12.3.10. Chiron Compounding Pharmacy
       12.3.11. MEDS Canadian Compounding Pharmacy
       12.3.12. Aurora Compounding
       12.3.13. Pace Pharmacy
       12.3.14. Victoria Compounding Pharmacy
       12.3.15. Pratt’s Compounding Pharmacy
       12.3.16. People’s Choice Pharmacy
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations